These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2225713)

  • 1. Electroencephalographic effects of benzodiazepines. I. Choosing an electroencephalographic parameter to measure the effect of midazolam on the central nervous system.
    Bührer M; Maitre PO; Hung O; Stanski DR
    Clin Pharmacol Ther; 1990 Nov; 48(5):544-54. PubMed ID: 2225713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam.
    Bührer M; Maitre PO; Crevoisier C; Stanski DR
    Clin Pharmacol Ther; 1990 Nov; 48(5):555-67. PubMed ID: 2225714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal.
    Schnider TW; Minto CF; Fiset P; Gregg KM; Shafer SL
    Anesthesiology; 1996 Mar; 84(3):510-9. PubMed ID: 8659777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men.
    Lu JF; Chen G; Xiang BR; An DK
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
    Mandema JW; Kuck MT; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
    Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
    Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electroencephalographic effects of subhypnotic doses of midazolam in healthy subjects and in brain disease patients].
    Navas E; Sariego M; Luis JC; Crespo A; Federero F; Sánchez-Peña J
    Rev Esp Anestesiol Reanim; 1993; 40(2):86-9. PubMed ID: 8451474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of midazolam and sarmazenil on the equine electroencephalogram during anaesthesia with halothane in oxygen.
    Johnson CB; Bloomfield M; Taylor PM
    J Vet Pharmacol Ther; 2003 Apr; 26(2):105-12. PubMed ID: 12667179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
    Mandema JW; Tukker E; Danhof M
    Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
    Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
    Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
    Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
    Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity.
    Van Steveninck AL; Mandema JW; Tuk B; Van Dijk JG; Schoemaker HC; Danhof M; Cohen AF
    Br J Clin Pharmacol; 1993 Aug; 36(2):109-15. PubMed ID: 8398578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
    Mandema JW; Tukker E; Danhof M
    J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.
    Hotz MA; Ritz R; Linder L; Scollo-Lavizzari G; Haefeli WE
    Br J Clin Pharmacol; 2000 Jan; 49(1):72-9. PubMed ID: 10606840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
    Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroencephalographic response following midazolam-induced general anesthesia: relationship to plasma and effect-site midazolam concentrations.
    Miyake W; Oda Y; Ikeda Y; Hagihira S; Iwaki H; Asada A
    J Anesth; 2010 Jun; 24(3):386-93. PubMed ID: 20229000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects.
    Ebert U; Oertel R; Kirch W
    Clin Pharmacol Ther; 2000 May; 67(5):538-48. PubMed ID: 10824633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.